0
Skip to Content
Welcome to the Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels
Welcome to the Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels
Home
ANGELS
FOR ENTREPRENEURS
Folder: RESOURCES
Back
Current Portfolio
Exits
Cambridge Angels Founded Companies
Angel Interviews
Portfolio Interviews
Portfolio News
Ecosystem News
Pitch deck template
Member's Portal
Apply to Cambridge Angels

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

8 Apr
Written by Alexandra Collingbourne
Alexandra Collingbourne
Previous
Previous

Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition

Next
Next

Privitar Launches New, Seamless Native Pattern to Protect Sensitive Data on AWS

LI-In-Bug_small.png

Privacy